Related Experiment Videos
Reduced triclosan susceptibility in methicillin-resistant Staphylococcus epidermidis
Molly B Schmid1, Nachum Kaplan
1Affinium Pharmaceuticals, Inc., Toronto, Ontario M5J 1V6, Canada.
Antimicrobial Agents and Chemotherapy
|March 30, 2004
Summary
Recent clinical isolates of Staphylococcus aureus show high susceptibility to triclosan. However, Staphylococcus epidermidis, especially methicillin-resistant strains, exhibit decreased susceptibility to this common antimicrobial agent.
Area of Science:
- Microbiology
- Antimicrobial Resistance
Background:
- Triclosan is a widely used antimicrobial agent.
- Understanding bacterial susceptibility to triclosan is crucial for public health.
- Staphylococcus species are common human pathogens.
Purpose of the Study:
- To determine the minimal inhibitory concentrations (MICs) of triclosan against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis.
- To investigate potential differences in triclosan susceptibility between methicillin-resistant and methicillin-sensitive Staphylococcus epidermidis.
Main Methods:
- Minimal Inhibitory Concentration (MIC) determination was performed.
- Clinical isolates of Staphylococcus aureus (n=100) and Staphylococcus epidermidis (n=96) were tested.
- Susceptibility testing included differentiation between methicillin-resistant and methicillin-sensitive Staphylococcus epidermidis.
Main Results:
- Staphylococcus aureus isolates were highly susceptible to triclosan (MIC(50) = 0.12 microg/ml, MIC(90) = 0.25 microg/ml).
- Staphylococcus epidermidis isolates showed lower susceptibility (MIC(50) = 0.12 microg/ml, MIC(90) = 8 microg/ml).
- Decreased triclosan susceptibility was more common in methicillin-resistant Staphylococcus epidermidis compared to methicillin-sensitive strains.
Conclusions:
- Clinical isolates of Staphylococcus aureus remain highly susceptible to triclosan.
- Staphylococcus epidermidis demonstrates reduced susceptibility to triclosan, particularly methicillin-resistant strains.
- These findings highlight the need for ongoing surveillance of antimicrobial resistance patterns.